Interdisziplinäre Behandlung des Rektumkarzinoms

Schlüsselwörter

Gastrointestinale Onkologie - Rektumkarzinom - totale mesorektale Exzision (TME) - neoadjuvante Radiochemotherapie

Key words

gastroinestinal oncology - rectal cancer - total mesorectal excision (TME) - preoperative chemoradiotherapy

Literatur

• 1 Adam R, Pascal G, Castaing D. et al . Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?.  Ann Surg. 2004;  240 1052-1061
• 2 Andre N, Schmiegel W. Chemoradiotherapy for colorectal cancer.  Gut. 2005;  54 1194-1202
• 3 Bujko K, Nowacki M P, Nasierowska-Guttmejer A. et al . Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy.  Radiother Oncol. 2004;  72 15-24
• 4 Camma C, Giunta M, Fiorica F, Pagliaro L, Craxi A, Cottone M. Preoperative radiotherapy for resectable rectal cancer: A meta-analysis.  JAMA. 2000;  284 1008-1015
• 5 Colorectal Cancer Collaborative Group . Surgery for colorectal cancer in elderly patients: a systematic review.  Lancet. 2000;  356 968-974
• 6 Cunningham D, Humblet Y, Siena S. et al . Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.  N Engl J Med. 2004;  351 337-345
• 7 de Gramont A, Figer A, Seymour M. et al . Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.  J Clin Oncol. 2000;  18 2938-2947
• 8 Douillard J Y, Cunningham D, Roth A D. et al . Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial.  Lancet. 2000;  355 1041-1047
• 9 Fernandez F G, Ritter J, Goodwin J W, Linehan D C, Hawkins W G, Strasberg S M. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases.  J Am Coll Surg. 2005;  200 845-853
• 10 Giacchetti S, Perpoint B, Zidani R. et al . Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer.  J Clin Oncol. 2000;  18 136-147
• 11 Goldberg R M, Sargent D J, Morton R F. et al . A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.  J Clin Oncol. 2004;  22 23-30
• 12 Grothey A, Sargent D, Goldberg R M, Schmoll H J. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment.  J Clin Oncol. 2004;  22 1209-1214
• 13 Hurwitz H, Fehrenbacher L, Novotny W. et al . Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.  N Engl J Med. 2004;  350 2335-2342
• 14 Kapiteijn E, Marijnen C A, Nagtegaal I D. et al. Dutch Colorectal Cancer Group . Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.  N Engl J Med. 2001;  345 638-646
• 15 Kehoe J, Khatri V P. Staging and prognosis of colon cancer.  Surg Oncol Clin N Am. 2006;  15 129-146
• 16 MacFarlane J K, Ryall R D, Heald R J. Mesorectal excision for rectal cancer.  Lancet. 1993;  341 457-460
• 17 Saltz L B, Cox J V, Blanke C. et al . Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group.  N Engl J Med. 2000;  343 905-914
• 18 Sauer R, Becker H, Hohenberger W. et al. German Rectal Cancer Study Group . Preoperative versus postoperative chemoradiotherapy for rectal cancer.  N Engl J Med. 2004;  351 1731-1740
• 19 Schmiegel W, Pox C, Adler G. et al . S3-Leitlinienkonferenz „Kolorektales Karzinom” 2004.  Z Gastroenterol. 2004;  42 1129-1177
• 20 Swedish Rectal Cancer Trial . Improved survival with preoperative radiotherapy in resectable rectal cancer.  N Engl J Med. 1997;  336 980-987
• 21 Tournigand C, Andre T, Achille E. et al . FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study.  J Clin Oncol. 2004;  22 229-237
• 22 Willis S, Schumpelick V. Rekonstruktion nach Rektumresektion.  Chirurg. 2004;  75 13-20